این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Blood and Cancer، جلد ۱۱، شماره ۱، صفحات ۱۳-۱۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی The Effect of Hydration Therapy with and without Magnesium Sulfate on Prevention of Cisplatin-Induced Nephrotoxicity
چکیده انگلیسی مقاله Background: Cisplatin is an antineoplastic agent used to treat many malignancies; however, the main side effect of cisplatin is nephrotoxicity. The aim of this study was to evaluate the effect of hydration therapy with and without magnesium on prevention of cisplatin-induced nephrotoxicity. Methods: This retrospective study was performed on 46 patients with malignancy who were candidate to receive cisplatin as their protocol for chemotherapy during years 2011-2016. Of these, 22 patients were treated with hydration and magnesium sulfate (1 gr magnesium sulfate 50% and 10 mEq potassium chloride 15% in 1000 ml normal saline before and after cisplatin administration) and 24 patients were treated with hydration alone. Cisplatin was administered in cycles every 21 days. Serum sodium, Potassium, creatinine (sCr) and creatinine clearance (CrCl) were assessed before each chemotherapy cycle and after the last course of chemotherapy. Results: There was significant difference between two studied groups in post chemotherapy sCr and Potassium (P< 0.05); however, no significant difference was observed between two groups in serum magnesium and sodium levels (P>0.05). In terms of sCr, as nephrotoxicity index, the absolute risk of nephrotoxicity in patients receiving hydration with magnesium was 19% more than the other group. The relative risk of nephrotoxicity in patients receiving hydration with magnesium was 4.4 fold more than another group. Conclusion: Risk of cisplatin-induced nephrotoxicity in patients receiving hydration with magnesium sulfate was higher than group of patients not receiving magnesium besides hydration.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Farzaneh Ashrafi
Associate Professor, Department of Hematology and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


| Masih Erfani
Acquired Immunodeficiency research Centre, Isfahan University of Medical Sciences, Isfahan, Iran


| Sarah Mousavi
Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
نشانی اینترنتی http://ijbc.ir/browse.php?a_code=A-10-403-1&slc_lang=en&sid=1
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/98/article-98-1483138.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Adults Hematology & Oncology
نوع مقاله منتشر شده پژوهشی
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات